Dumond, Aurore Brachet, Etienne Durivault, Jérôme Vial, Valérie Puszko, Anna K. Lepelletier, Yves Montemagno, Christopher Pagnuzzi-Boncompagni, Marina Hermine, Olivier Garbay, Christiane
...
Published in
Journal of Experimental & Clinical Cancer Research
BackgroundDespite the improvement of relapse-free survival mediated by anti-angiogenic drugs like sunitinib (Sutent®), or by combinations of anti-angiogenic drugs with immunotherapy, metastatic clear cell Renal Cell Carcinoma (mccRCC) remain incurable. Hence, new relevant treatments are urgently needed. The VEGFs coreceptors, Neuropilins 1, 2 (NRP1...
Mathews, Jean Hannon, Breffni Zimmermann, Camilla
Published in
Current Treatment Options in Oncology
Evidence from randomized controlled trials and meta-analyses has shown that early integration of specialized palliative care improves symptoms and quality of life for patients with advanced cancer. There are various models of early integration, which may be classified based on setting of care and method of palliative care referral. Most successful ...
Daisy, Precilla S Anitha, T. S.
Published in
Medical Oncology
Gliomas are one of the most devastating primary brain tumors which impose significant management challenges to the clinicians. The aggressive behaviour of gliomas is mainly attributed to their rapid proliferation, unravelled genomics and the blood–brain barrier which protects the tumor cells from chemotherapeutic regimens. Suspects of brain tumors ...
Rodriguez, Robin Raquel Rizwan, Saleha Alhamad, Khaled Finley, Gene Grant
Published in
Journal of Medical Case Reports
BackgroundPheochromocytomas are a subset of paragangliomas, which are a rare group of neural crest cell-derived tumors. Malignant cases of both pheochromocytomas and paragangliomas are even rarer, and currently there is no standard of care. This case report details the use of off-label immunotherapy and its efficacy in the management of the aforeme...
Delport, Johannes Eduard Makamba, Khanyisa
Published in
African Journal of Urology
BackgroundBladder cancer is the 17th most common cancer in the female population. Most bladder cancers are of urothelial origin. Sarcomas of the bladder are very uncommon.Case presentationThis case concerns a 57-year-old female from a rural town in the Eastern Cape who was diagnosed with myxoid/round cell liposarcoma of the bladder. After the initi...
WAELLI, Mathias Minvielle, Etienne Acero, Maria Ximena Ba, Khouloud Lalloué, Benoit
Published in
BMC Health Services Research
BackgroundA patient-centred approach is increasingly the mandate for healthcare delivery, especially with the growing emergence of chronic conditions. A relevant but often overlooked obstacle to delivering person-centred care is the identification and consideration of all demands based on individual experience, not only disease-based requirements. ...
Iannessi, Antoine Beaumont, Hubert Liu, Yan Bertrand, Anne-Sophie
Published in
Insights into Imaging
Response Evaluation Criteria In Solid Tumors (RECIST) is still the predominant criteria base for assessing tumor burden in oncology clinical trials. Despite several improvements that followed its first publication, RECIST continues to allow readers a lot of freedom in their evaluations. Notably in the selection of tumors at baseline. This subjectiv...
Ng, Diane Gallaway, M. Shayne Huang, Grace C. Famolaro, Theresa Boehm, Jennifer Stachon, Karen Rohan, Elizabeth A.
Published in
BMC Health Services Research
BackgroundWe sought to understand barriers and facilitators to implementing distress screening (DS) of cancer patients to inform and promote uptake in cancer treatment facilities. We describe the recruitment and data collection challenges and recommendations for assessing DS in oncology treatment facilities.MethodsWe recruited CoC-accredited facili...
Banerjee, Smita C Haque, Noshin Bylund, Carma L Shen, Megan J Rigney, Maureen Hamann, Heidi A Parker, Patricia A Ostroff, Jamie S
Published in
Translational behavioral medicine
Most lung cancer patients report perceiving stigma surrounding their diagnosis, and routine clinical interactions with their health care providers (HCPs) are reported as a common source. The adverse effects of lung cancer stigma are associated with several adverse psychosocial and behavioral outcomes. One potential clinician-level intervention targ...
Hanna, Catherine R. Boyd, Kathleen A. Jones, Robert J.
Published in
Health Research Policy and Systems
BackgroundPerforming cancer research relies on substantial financial investment, and contributions in time and effort from patients. It is therefore important that this research has real life impacts which are properly evaluated. The optimal approach to cancer research impact evaluation is not clear. The aim of this study was to undertake a systema...
